Masimo Corporation
MASI
Rangering i aksjer
#2164
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Aksjekurs
$179.95
Sist synkronisert: 2026-06-12
Markedsverdi
$9.42B
Endring (1 dag)
0.00%
Endring (1 år)
22.41%
Land
US
Handel Masimo Corporation (MASI)
Kategori
Healthcare
EPS for Masimo Corporation (MASI)
EPS per April 2026 TTM: $1.44
Ifølge de siste økonomiske rapportene og aksjekursen til Masimo Corporation er selskapets nåværende EPS (TTM) $1.44. Ved slutten av 2023 hadde selskapet en EPS på $1.54, en nedgang sammenlignet med EPS-en i 2022 som var $2.68.
EPS-historikk for Masimo Corporation fra 2002 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $1.44 | -125.17% |
| 2024 | $-5.72 | -471.43% |
| 2023 | $1.54 | -42.54% |
| 2022 | $2.68 | -35.58% |
| 2021 | $4.16 | -5.24% |
| 2020 | $4.39 | 19.62% |
| 2019 | $3.67 | 6.38% |
| 2018 | $3.45 | 42.56% |
| 2017 | $2.42 | -61.46% |
| 2016 | $6.28 | 287.65% |
| 2015 | $1.62 | 21.80% |
| 2014 | $1.33 | 29.13% |
| 2013 | $1.03 | -4.63% |
| 2012 | $1.08 | 0.93% |
| 2011 | $1.07 | -14.40% |
| 2010 | $1.25 | 35.87% |
| 2009 | $0.92 | 61.40% |
| 2008 | $0.57 | -19.72% |
| 2007 | $0.71 | -81.27% |
| 2006 | $3.79 | 286.73% |
| 2005 | $0.98 | -990.91% |
| 2004 | $-0.11 | -45.00% |
| 2003 | $-0.20 | 3,673.58% |
| 2002 | $-0.01 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $3.11 | 115.97% |
US
|
|
| $3.59 | 149.31% |
IE
|
|
| $9.73 | 575.69% |
US
|
|
| $2.48 | 72.22% |
US
|
|
| - | - |
DE
|
